News & Announcements
OBI-992 Shortlisted as the Most Promising Clinical Candidate in the 11th Annual World ADC Awards
OBI-992 has been approved by US FDA for Orphan Drug Designation for the treatment of gastric cancer
OBI’s Proprietary ADC Platform GlycOBI® Seeks Collaborative Partnerships for Development
OBI Shares Opportunities and Challenges of ADC Development at BioAsia2024
Events
2024 2nd ADC Linker & Conjugation Summit
- 2024.Aug.20 ~ 2024.Aug.22
- W Boston 100 Stuart Street, Boston, MA 02116, United States
- Event Time2024.Aug.20 ~ 2024.Aug.22
- Event LocationW Boston 100 Stuart Street, Boston, MA 02116, United States
- Video URLhttps://adc-linker-conjugation.com/
- Published Date2024.Aug.13
2024 BIO Asia-Taiwan
- 2024.Jul.24 ~ 2024.Jul.28
- TaiNEX, (No. 1, Jingmao 2nd Rd., Nangang Dist., Taipei City), Taiwan (R.O.C.)
- Event Time2024.Jul.24 ~ 2024.Jul.28
- Event LocationTaiNEX, (No. 1, Jingmao 2nd Rd., Nangang Dist., Taipei City), Taiwan (R.O.C.)
- Video URLhttps://bioasiataiwan.com/
- Published Date2024.Jul.05
2024 Annual Shareholders’ Meeting
- 2024.Jun.17 at 09:00 AM
- Masterlink Securities Education and Training Center
- Event Time2024.Jun.17
- Event LocationMasterlink Securities Education and Training Center
- Published Date2024.May.14
Announcements
Latest announcements
